Dr. Rabab Kamel

Professor
Department of Pharmaceutical Technology, National Research Center, Egypt

Highest Degree
PostDoc. Student in Pharmaceutical Technology from National Research Centre, Egypt

My URL
https://livedna.org/20.1255

Share this Profile

Biography

Dr. Rabab Kamel is a distinguished Professor of Pharmaceutical Technology at the National Research Centre in Egypt with an exceptional career marked by impactful contributions to science and leadership. Ranked among the top 2% of scientists worldwide, she has a strong publication record and is an editorial member for several Scopus-indexed scientific journals. As a recipient of some awards and a patent holder for an innovative pharmaceutical formulation, her expertise bridges sustainable research with practical application. Further solidifying her influence, Prof. Rabab Kamel is a member of various national and international committees and associations, and is acting towards scientific advancement and innovation together with bridging academia and industry.

Area of Interest:

Pharmacology and Toxicology
Pharmaceutics
Drug Delivery
Pharmacy
Polymers

Selected Publications

  1. Kamel, R., R. El-batanony and A. Salama, 2019. Pioglitazone-loaded three-dimensional composite polymeric scaffolds: a proof of concept study in wounded diabetic rats. Int. J. Pharmaceutics, Vol. 570. 10.1016/j.ijpharm.2019.118667.
    CrossRef  |  Direct Link  |  

  2. Kamel, R., H. Abbas and N.M. Shaffie, 2019. Development and evaluation of PLA-coated co-micellar nanosystem of resveratrol for the intra-articular treatment of arthritis. Int. J. Pharmaceutics, Vol. 569. 10.1016/j.ijpharm.2019.118560.
    CrossRef  |  Direct Link  |  

  3. Kamel, R., 2019. Nanotherapeutics as promising approaches to combat fungal infections. Drug Dev. Res., 80: 535-545.
    CrossRef  |  Direct Link  |  

  4. Abbas, H. and R. Kamel, 2019. Potential role of resveratrol-loaded elastic sorbitan monostearate nanovesicles for the prevention of UV-induced skin damage. J. Liposome Res., 30: 45-53.
    CrossRef  |  Direct Link  |  

  5. Kamel, R., H. Abbas and M. El-Naa, 2018. Composite carbohydrate interpenetrating polyelectrolyte nano-complexes (IPNC) as a controlled oral delivery system of citalopram HCI for pediatric use: in-vitro/in-vivo evaluation and histopathological examination. Drug Delivery Transl. Res., 8: 657-669.
    CrossRef  |  Direct Link  |  

  6. Kamel, R. and H. Abbas, 2018. Rational for the use of coconut oil-based anti-mycotic pessaries to combat recurrent vaginal infection: in vitro/in vivo evaluation and preliminary prospective clinical investigation. Int. J. Appl. Pharm., 10: 159-166.
    CrossRef  |  Direct Link  |  

  7. Kamel, R. and H. Abbas, 2018. PLGA-based monolithic filaments prepared by hot-melt extrusion: in-vitro comparative study. Ann. Pharm. Françaises, 76: 97-106.
    CrossRef  |  Direct Link  |  

  8. Abbas, H., R. Kamel and N. El-Sayed, 2018. Dermal anti-oxidant, anti-inflammatory and anti-aging effects of compritol ATO-based resveratrol colloidal carriers prepared using mixed surfactants. Int. J. Pharm., 541: 37-47.
    CrossRef  |  Direct Link  |  

  9. Kamel, R., H. Abbas and A. Fayez, 2017. Diosmin/essential oil combination for dermal photo-protection using a lipoid colloidal carrier. J. Photochem. Photobiol. B: Biol., 170: 49-57.
    CrossRef  |  Direct Link  |  

  10. Kamel, R. and H. Abbas, 2017. A multi-microcarrier of metronidazole-biopolymers complexes as a potential vaginal delivery system. Int. J. Polym.ic Mater. Polym.ic Biomater., 67: 239-246.
    CrossRef  |  Direct Link  |  

  11. Kamel, R., A.H. Salama and A.A. Mahmoud, 2016. Development and optimization of self-assembling nanosystem for intra-articular delivery of indomethacin. Int. J. Pharm., 515: 657-668.
    CrossRef  |  Direct Link  |  

  12. Kamel, R., 2016. Multiparticulate carriers for controlled oral drug delivery. Pharm. Sci. Technol., 1: 1-3.
    CrossRef  |  Direct Link  |  

  13. Ammar, H.O., M. Ghorab, R. Kamel and A.H. Salama, 2016. Design and optimization of gastro-retentive microballoons for enhanced bioavailability of cinnarizine. Drug Deliv. Transl. Res., 6: 210-224.
    CrossRef  |  Direct Link  |  

  14. Ammar, H.O., M. Ghorab, R. Kamel and A.H. Salama, 2016. A trial for the design and optimization of pH-sensitive microparticles for intestinal delivery of cinnarizine. Drug Deliv. Transl. Res., 6: 195-209.
    CrossRef  |  Direct Link  |  

  15. Ammar, H.O., M. Ghorab, S. El-Nahhas and R. Kamel, 2009. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part II: biological evaluation. AAPS Pharm. Sci. Tech., 10: 1065-1070.
    PubMed  |  Direct Link  |  

  16. Ammar, H.O., M. Ghorab, S. El-Nahhas and R. Kamel, 2009. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part I: Physicochemical evaluation. AAPS Pharm. Sci. Tech., 10: 7-20.
    PubMed  |  Direct Link  |  

  17. Ammar, H.O., M. Ghorab, S. El-Nahhas and R. Kamel, 2007. Evaluation of chemical penetration enhancers for transdermal delivery of aspirin. Asian J. Pharm. Sci., 2: 96-105.
    Direct Link  |  

  18. Ammar, H.O., M. Ghorab, S. El-Nahhas and R. Kamel, 2006. Design of A transdermal delivery system for aspirin as an antithrombotic drug. J. Pharm. Phamacol., 327: 81-88.
    CrossRef  |  PubMed  |  
Member since June, 2010